NUI Galway has launched a new Masters programme in Biomedical Genomics, the first of its kind to be offered in Ireland. This programme places NUI Galway at the forefront of training the next generation of scientists and clinicians in the use of cutting-edge DNA sequencing technologies, both within fundamental scientific discovery and in clinical applications.
Based at the School of Mathematics, Statistics and Applied Mathematics, this Masters is an inter-disciplinary programme drawing on expertise from across the University. The programme has been specifically designed to address the growing need for scientists with the quantitative skills necessary to help realise the enormous potential of sequencing-based technologies to deliver on the promise of personalised medicine in order to better understand, diagnose, and treat disease.
Keynote speaker at the launch, Dr John Greally, an NUI Galway graduate, Professor of Genetics and Medicine and Director of the Center for Epigenomics at the Einstein College of Medicine in New York, said: “As both a clinician and director of a research laboratory, I see on a daily basis how contributions from genomics scientists in areas such as drug discovery and diagnosis of rare genetic diseases are transforming the field of medicine. I am really excited by this new programme because it provides the unique combination of molecular and analytical skills that are critical in order to take advantage of the current wave of innovation in genomics-based technologies. With this programme, I can see NUI Galway establishing itself as a major centre for biomedical genomics training and research in Europe.”
Professor Cathal Seoighe, Director of the NUI Galway programme added: “This exciting new programme will bring together students from diverse academic backgrounds who share the common goal of learning how to apply newly-developed genomics technologies to biomedical problems. I’m delighted that NUI Galway and the College of Science are leading the way in recognising the transformative potential of genomics science both in human health and in basic research.”
Graduates of the programme will have a highly marketable and transferable combination of computational and analytical skills as well as specialist knowledge of the application of these skills in the analysis of genomics data. They will be well placed to seek employment in the new field of precision medicine, in biotechnology and pharmaceutical companies making use of genomics technologies, or in research roles in both industry and academic settings.
This programme will have its first intake of students in the academic year 2016/17. For further information on the MSc in Biomedical Genomics visit http://bioinf.nuigalway.ie.
